Forecast & Rating2 analysts currently cover CytoSorbents, of which 0 give a positive rating. The average price target is $47.50, about 1072.8% upside from the current price of $4.05. Coverage is limited, so the data is for reference only. Data as of Sep 8, 2026; this does not constitute investment advice.
Sep 3, 2026Price forecast
$47.501072.84%
Forecast & RatingHold
1analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 28, 2026
Forecast met0.0%
Stock price$4.05
Avg. target$47.5
High target$80
Low target$15
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.